5-148120311-GAAA-GAAAA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006846.4(SPINK5):c.2468dupA(p.Lys824fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,361,340 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SPINK5
NM_006846.4 frameshift
NM_006846.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-148120311-G-GA is Pathogenic according to our data. Variant chr5-148120311-G-GA is described in ClinVar as [Pathogenic]. Clinvar id is 5268.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINK5 | NM_006846.4 | c.2468dupA | p.Lys824fs | frameshift_variant | 26/33 | ENST00000256084.8 | NP_006837.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINK5 | ENST00000256084.8 | c.2468dupA | p.Lys824fs | frameshift_variant | 26/33 | 1 | NM_006846.4 | ENSP00000256084.7 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 15AN: 146014Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 genomes
AF:
AC:
15
AN:
146014
Hom.:
Cov.:
32
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00133 AC: 175AN: 131578Hom.: 0 AF XY: 0.00120 AC XY: 84AN XY: 70102
GnomAD3 exomes
AF:
AC:
175
AN:
131578
Hom.:
AF XY:
AC XY:
84
AN XY:
70102
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000220 AC: 299AN: 1361340Hom.: 0 Cov.: 34 AF XY: 0.000211 AC XY: 143AN XY: 676992
GnomAD4 exome
AF:
AC:
299
AN:
1361340
Hom.:
Cov.:
34
AF XY:
AC XY:
143
AN XY:
676992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000103 AC: 15AN: 146078Hom.: 0 Cov.: 32 AF XY: 0.0000847 AC XY: 6AN XY: 70866
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
15
AN:
146078
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
70866
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Netherton syndrome Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 29, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.113%). Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000005268 / PMID: 10835624). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 26, 2022 | This sequence change creates a premature translational stop signal (p.Lys824Glufs*4) in the SPINK5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPINK5 are known to be pathogenic (PMID: 11511292, 11841556). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Netherton syndrome (PMID: 10835624, 26031502). This variant is also known as 2468insA. ClinVar contains an entry for this variant (Variation ID: 5268). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2017 | The c.2468dupA pathogenic variant in the SPINK5 gene has been reported previously in the homozygous state or as a single variant in patients with Netherton syndrome (Chavanas et al., 2000; Bitoun et al., 2002; Raghunath et al., 2004). It causes a frameshift starting with codon Lysine 824, changes this amino acid to a Glutamic acid residue, and creates a premature Stop codon at position 4 of the new reading frame, denoted p.Lys824GlufsX4. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2468dupA variant is observed in 17/7814 (0.22%) alleles from individuals of African background, in large population cohorts, and no individuals were reported to be homozygous (Lek et al., 2016). We interpret c.2468dupA as a pathogenic variant. - |
Ichthyosis linearis circumflexa Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 15, 2023 | Variant summary: SPINK5 c.2468dupA (p.Lys824GlufsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.0013 in 131578 control chromosomes (gnomAD). c.2468dupA (aka 2468insA) has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Netherton syndrome (e.g. Chavanas_2000, Bitoun_2002). These publications also reported dramatic reduction in the SPINK5 mRNA in keratinocytes derived from homozygous patients, suggestive of nonsense-mediated mRNA decay (Bitoun_2002). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 10835624, 11841556). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at